Table 1.
Cell Line | Mouse | Inoculation site | Liver met? | Other met? | Study purpose | Reference |
---|---|---|---|---|---|---|
MDA-MB-435 | Female nude | Mammary fat pad | Yes | Yes | Use of surgical orthotopic implantation | [7] |
MDA-MB-435 | Female athymic NU/NU | Right second mammary gland | Yes | Yes | Optical imaging | [8] |
4T1 | Female BALB/c | Mammary fat pad | Yes | Yes | Effect of bisphosphonate | [9] |
4T1 | Female BALB/c | Mammary fat pad | Yes | Yes | Effect of factor 4 | [10] |
4T1 | Female BALB/c | Mammary fat pad | Yes | Yes | Use of dabigatran | [11] |
4T1 | Female BALB/c | Mammary fat pad | Yes | Yes | Effect of R428 | [12] |
4T1 | BALB/cfC3H | Mammary fat pad | Yes | Yes | Imaging | [13] |
4T1/luc | BALB/c | Mammary fat pad | Yes | Yes | Effect of zoledronic acid | [14] |
MDA-MB-231 | Female NCr nu/nu | Mammary fat pad | Yes | Yes | Effect of pro-matrix metalloproteinase-2 | [15] |
MDA-MB-231 | Female athymic nude | Mammary fat pad | Yes | Yes | Effect of GLV-1h153 in TNBC | [16] |
MDA-MB-231 | BALB/cAnN.CG-Foxn1 nu/CrINar | Tail vein | Yes | No | Effect of VP1 | [17] |
MDA-MB-231 | Mammary pat | Yes | Yes | Effect of PEDF | [18] | |
MDA-MB-231 | Female nude | Mammary fat pad | Yes | Yes | Effect of CH50 | [19] |
MDA-MB-231/luc | Female Rag2-/-II2rg-/- | Mammary fat pad | Yes | Yes | Effect of phenytoin on TNBC | [20] |
4TLM | BALB-c | Right upper mammary gland | Yes | Yes | Multi metastatic model | [21] |
4THM | BALB-c | Second right chest mammary pad | Yes | Yes | Effect of semapimod | [22] |